| Announce Date | 11/04/2025 |
| EPS Normalized Actual | $1.08 (Miss by $-0.09) |
| EPS GAAP Actual | $1.08 (Miss by $-0.09) |
| Revenue Actual | $0.463B |
| Revenue Surprise | Beat by $463M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $1.61639 |
| EPS GAAP Estimate | $1.61639 |
| Revenue Estimate | $0.580724722B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Sep 2028 | 6.15 | 8.14 | 5.96796 | 6.37883 | 1 |
| Sep 2027 | 0 | INF | 0 | 0 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | -16.13 | -16.13 | 0.463B | -17.49% | 463M |
| FQ1 2025 (Mar 2025) | 0.38 | 0.38 | 0.479B | -106.47% | 479M |
| FQ4 2024 (Dec 2024) | -3.51 | -3.51 | 0.405B | -109.38% | 405M |
| FQ3 2024 (Sep 2024) | -0.31 | -0.31 | 0.87B | 40.46% | 870M |
| FQ2 2024 (Jun 2024) | 0.28 | 0.28 | 0.544B | -0.37% | 544M |
| FQ1 2024 (Mar 2024) | 2.43 | 2.43 | 0.989B | -2.02% | 989M |
| FQ4 2023 (Dec 2023) | 0.54 | 0.54 | 0.848B | 38.09% | 848M |
| FQ3 2023 (Sep 2023) | -0.0781 | -0.0781 | 0.518B | -21.81% | 518M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
1.61639
Consensus Revenue Estimates
0.580724722B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2028 (Jun 2028) | 1.70126 | -- | 1.63474 | 1.76951 | 2 |
| FQ1 2028 (Mar 2028) | 1.68134 | -- | 1.6156 | 1.74879 | 2 |
| FQ4 2027 (Dec 2027) | 0.35278 | -- | 0.33899 | 0.36693 | 1 |
| FQ2 2027 (Jun 2027) | 1.86418 | -- | 1.72566 | 1.98444 | 1 |
| FQ1 2027 (Mar 2027) | 1.80124 | -- | 1.66739 | 1.91744 | 1 |
| FQ4 2026 (Oct 2026) | 1.99606 | -- | 1.94601 | 2.0376 | 3 |
| FQ3 2026 (Jul 2026) | 2.05068 | -- | 1.99926 | 2.09336 | 4 |
| FQ2 2026 (Jun 2026) | 2.0528 | 885.76 | 1.99147 | 2.09975 | 4 |
| FQ1 2026 (Mar 2026) | 1.96607 | 80.67 | 1.90734 | 2.01104 | 5 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2028 (Jun 2028) | 0.51B | -- | 0.5B | 0.53B | 1 |
| FQ1 2028 (Mar 2028) | 0.54B | -- | 0.52B | 0.55B | 1 |
| FQ4 2027 (Dec 2027) | 0.43B | -- | 0.42B | 0.44B | 2 |
| FQ2 2027 (Jun 2027) | 0.56B | -- | 0.52B | 0.58B | 2 |
| FQ1 2027 (Mar 2027) | 0.57B | -- | 0.53B | 0.59B | 2 |
| FQ4 2026 (Oct 2026) | 0.61B | -- | 0.6B | 0.62B | 4 |
| FQ3 2026 (Jul 2026) | 0.61B | -- | 0.6B | 0.62B | 4 |
| FQ2 2026 (Jun 2026) | 0.65B | 28.47 | 0.63B | 0.66B | 4 |
| FQ1 2026 (Mar 2026) | 0.66B | 26.97 | 0.64B | 0.67B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
4
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | -16.13 | -16.13 | 100% | |
| FQ1 2025 (Mar 2025) | 0.38 | 0.38 | 100% | |
| FQ4 2024 (Dec 2024) | -3.51 | -3.51 | 100% | |
| FQ3 2024 (Sep 2024) | -0.31 | -0.31 | 100% | |
| FQ2 2024 (Jun 2024) | 0.28 | 0.28 | 100% | |
| FQ1 2024 (Mar 2024) | 2.43 | 2.43 | 100% | |
| FQ4 2023 (Dec 2023) | 0.54 | 0.54 | 100% | |
| FQ3 2023 (Sep 2023) | -0.0781 | -0.0781 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | $0B | $0.46B | $463M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0.48B | $479M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.41B | $405M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.87B | $870M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.54B | $544M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.99B | $989M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.85B | $848M | 100% |
| FQ3 2023 (Sep 2023) | $0B | $0.52B | $518M | 100% |